These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21949920)

  • 1. Ring-fencing a budget for cancer drugs: is it fair?
    Graham J; Cassidy J; Hughes D; Duerden M
    J R Coll Physicians Edinb; 2011 Sep; 41(3):224-8. PubMed ID: 21949920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Tale of Two Thresholds: A Framework for Prioritization within the Cancer Drugs Fund.
    Leigh S; Granby P
    Value Health; 2016; 19(5):567-76. PubMed ID: 27565274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NHS will not pay for drugs that offer little clinical benefit, says cancer fund boss.
    Kmietowicz Z
    BMJ; 2015 Jan; 350():h125. PubMed ID: 25569117
    [No Abstract]   [Full Text] [Related]  

  • 4. New "managed access" process for Cancer Drugs Fund to go ahead, NHS England confirms.
    Mayor S
    BMJ; 2016 Feb; 352():i1208. PubMed ID: 26926879
    [No Abstract]   [Full Text] [Related]  

  • 5. Cancer Drugs Fund of minimal benefit.
    Burki TK
    Lancet Oncol; 2017 Jun; 18(6):e305. PubMed ID: 28483412
    [No Abstract]   [Full Text] [Related]  

  • 6. European perspective on the costs and cost-effectiveness of cancer therapies.
    Drummond MF; Mason AR
    J Clin Oncol; 2007 Jan; 25(2):191-5. PubMed ID: 17210939
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MPs find no evidence that Cancer Drugs Fund was spent wisely.
    Hawkes N
    BMJ; 2016 Feb; 352():i755. PubMed ID: 26850036
    [No Abstract]   [Full Text] [Related]  

  • 8. Reforming the cancer drug fund.
    Buxton M; Longworth L; Raftery J; Sculpher M; Towse A
    BMJ; 2014 Nov; 349():g7276. PubMed ID: 25432928
    [No Abstract]   [Full Text] [Related]  

  • 9. United healthcare, five oncology practices try bundled payments.
    Goozner M
    J Natl Cancer Inst; 2011 Jan; 103(1):8-10. PubMed ID: 21169535
    [No Abstract]   [Full Text] [Related]  

  • 10. The UK Cancer Drugs Fund Experiment and the US Cancer Drug Cost Problem: Bearing the Cost of Cancer Drugs Until It Is Unbearable.
    Prasad V; Mailankody S
    Mayo Clin Proc; 2016 Jun; 91(6):707-12. PubMed ID: 27261866
    [No Abstract]   [Full Text] [Related]  

  • 11. UK Cancer Drugs Fund to reassess 42 agents.
    Cagney H
    Lancet Oncol; 2015 Jan; 16(1):e8. PubMed ID: 25638560
    [No Abstract]   [Full Text] [Related]  

  • 12. Inequalities in oncology care: Economic consequences of high cost drugs.
    Niezen MG; Stolk EA; Steenhoek A; Uyl-De Groot CA
    Eur J Cancer; 2006 Nov; 42(17):2887-92. PubMed ID: 16979891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Unfunded promises as the UK health debate takes centre stage.
    Lancet Oncol; 2010 May; 11(5):401. PubMed ID: 20409754
    [No Abstract]   [Full Text] [Related]  

  • 14. Top-up insurance for cancer drugs.
    Sikora K
    Br J Hosp Med (Lond); 2007 Jun; 68(6):288-9. PubMed ID: 17639822
    [No Abstract]   [Full Text] [Related]  

  • 15. Cancer funding throughout the world.
    McCarthy M; Poses RM; Saghatchian M; de Pouvourville G; Tursz T; Gray A
    Lancet Oncol; 2004 Jul; 5(7):453-7. PubMed ID: 15231253
    [No Abstract]   [Full Text] [Related]  

  • 16. Key changes to cancer care in the UK.
    Br J Nurs; 2015 Feb 26-Mar 11; 24(4):S3. PubMed ID: 25723370
    [No Abstract]   [Full Text] [Related]  

  • 17. Access to expensive drugs in the NHS: myths and realities for cancer patients.
    Mehta AB; Low E
    Int J Clin Pract; 2007 Dec; 61(12):2126-9. PubMed ID: 17997811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost of hospital prescribing rose 15% in a year owing to new rheumatoid arthritis and cancer drugs.
    Hawkes N
    BMJ; 2014 Nov; 349():g6867. PubMed ID: 25404423
    [No Abstract]   [Full Text] [Related]  

  • 19. Charities raise alarm over changes to UK Cancer Drugs Fund.
    Burki TK
    Lancet Oncol; 2016 Jun; 17(6):e230. PubMed ID: 27210532
    [No Abstract]   [Full Text] [Related]  

  • 20. Development and economic trends in cancer therapeutic drugs: a 5-year update 2010-2014.
    Savage P; Mahmoud S
    Br J Cancer; 2015 Mar; 112(6):1037-41. PubMed ID: 25668005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.